1-5 of 5
Yongqian Shu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

HLA-I Evolutionary Divergence Confers Response to PD-1 Blockade plus Chemotherapy in Untreated Advanced Non–Small Cell Lung Cancer

Tao Jiang, Qiqi Jin, Jiahao Wang, Fengying Wu, Jian Chen, Gongyan Chen, Yunchao Huang, Jianhua Chen, Ying Cheng, QiMing Wang, Yueyin Pan, Jianying Zhou, Jianhua Shi, Xingxiang Xu, LiZhu Lin, Wei Zhang, Yiping Zhang, Yunpeng Liu, Yong Fang, Jifeng Feng, Zhehai Wang, Sheng Hu, Jian Fang, Yongqian Shu, Jiuwei Cui, Yi Hu, Wenxiu Yao, Xingya Li, Xiaoyan Lin, Rui Wang, Yongsheng Wang, Wei Shi, Gaohua Feng, Jun Ni, Beibei Mao, Dandan Ren, Huaibo Sun, Henghui Zhang, Luonan Chen, Caicun Zhou, Shengxiang Ren
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (23): 4830–4843.
https://doi.org/10.1158/1078-0432.CCR-23-0604
Published: 01 December 2023
View article titled, HLA-I Evolutionary Divergence Confers Response to PD-1 Blockade plus Chemotherapy in Untreated Advanced Non–Small Cell Lung Cancer
Open the PDF for HLA-I Evolutionary Divergence Confers Response to PD-1 Blockade plus Chemotherapy in Untreated Advanced Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

A Novel Third-generation EGFR Tyrosine Kinase Inhibitor Abivertinib for EGFR T790M-mutant Non–Small Cell Lung Cancer: a Multicenter Phase I/II Study

Qing Zhou, Lin Wu, Pei Hu, Tongtong An, Jianying Zhou, Li Zhang, Xiao-Qing Liu, Feng Luo, Xin Zheng, Ying Cheng, Nong Yang, Junling Li, Jifeng Feng, Baohui Han, Yong Song, Kai Wang, Li Zhang, Jian Fang, Hong Zhao, Yongqian Shu, Xiao-Yan Lin, Zhihong Chen, Bin Gan, Wan-Hong Xu, Wei Tang, Xiaoying Zhang, Jin-Ji Yang, Xiao Xu, Yi-Long Wu
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (6): 1127–1135.
https://doi.org/10.1158/1078-0432.CCR-21-2595
Published: 15 March 2022
View article titled, A Novel Third-generation EGFR Tyrosine Kinase Inhibitor Abivertinib for EGFR T790M-mutant Non–Small Cell Lung Cancer: a Multicenter Phase I/II Study
Open the PDF for A Novel Third-generation EGFR Tyrosine Kinase Inhibitor Abivertinib for EGFR T790M-mutant Non–Small Cell Lung Cancer: a Multicenter Phase I/II Study in another window
Includes: Supplementary data
Journal Articles

Biomarkers of Osimertinib Response in Patients with Refractory, EGFR-T790M–positive Non–Small Cell Lung Cancer and Central Nervous System Metastases: The APOLLO Study

Ligang Xing, Yueyin Pan, Yuankai Shi, Yongqian Shu, Jifeng Feng, Wei Li, Lejie Cao, Lifeng Wang, Wei Gu, Yong Song, Puyuan Xing, Yutao Liu, Wen Gao, Jiuwei Cui, Nana Hu, Rutian Li, Hua Bao, Yang Shao, Jinming Yu
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (23): 6168–6175.
https://doi.org/10.1158/1078-0432.CCR-20-2081
Published: 01 December 2020
View article titled, Biomarkers of Osimertinib Response in Patients with Refractory, EGFR-T790M–positive Non–Small Cell Lung Cancer and Central Nervous System Metastases: The APOLLO Study
Open the PDF for Biomarkers of Osimertinib Response in Patients with Refractory, EGFR-T790M–positive Non–Small Cell Lung Cancer and Central Nervous System Metastases: The APOLLO Study in another window
Includes: Supplementary data
Journal Articles

Genome-Wide Association Study of Prognosis in Advanced Non–Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy

Lingmin Hu, Chen Wu, Xueying Zhao, Rebecca Heist, Li Su, Yang Zhao, Baohui Han, Songyu Cao, Minjie Chu, Juncheng Dai, Jing Dong, Yongqian Shu, Lin Xu, Yijiang Chen, Yi Wang, Feng Lu, Yue Jiang, Dianke Yu, Hongyan Chen, Wen Tan, Hongxia Ma, Jiaping Chen, Guangfu Jin, Tangchun Wu, Daru Lu, David C. Christiani, Dongxin Lin, Zhibin Hu, Hongbing Shen
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (19): 5507–5514.
https://doi.org/10.1158/1078-0432.CCR-12-1202
Published: 30 September 2012
View article titled, Genome-Wide Association Study of Prognosis in Advanced Non–Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy
Open the PDF for Genome-Wide Association Study of Prognosis in Advanced Non–Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy in another window
Includes: Supplementary data
Journal Articles

A 3′-Untranslated Region Polymorphism in IGF1 Predicts Survival of Non–Small Cell Lung Cancer in a Chinese Population

Mingfeng Zhang, Zhibin Hu, Jinlin Huang, Yongqian Shu, Juncheng Dai, Guangfu Jin, Rong Tang, Jing Dong, Yijiang Chen, Lin Xu, Xinen Huang, Hongbing Shen
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (4): 1236–1244.
https://doi.org/10.1158/1078-0432.CCR-09-2719
Published: 15 February 2010
View article titled, A 3′-Untranslated Region Polymorphism in <em>IGF1</em> Predicts Survival of Non–Small Cell Lung Cancer in a Chinese Population
Open the PDF for A 3′-Untranslated Region Polymorphism in <em>IGF1</em> Predicts Survival of Non–Small Cell Lung Cancer in a Chinese Population in another window